Strimvelis 1-10 x 106 cells/mL dispersion for infusion clinical trials

StroKE34 Study Protocol: a randomized Controlled Phase IIa trial of intra-arterial Cd34+ Cells in acute ischemic Stroke

This study looks at a new treatment involving special cells (Cd34+ cells) for people who have recently had a stroke. It aims to see if this treatment can limit the damage to the brain. Researchers will measure the affected brain area three months later.